A pivotal step in the initiation of T-cell immunity is the presentation of antigenic peptides by major histocompatibility complex (MHC) expressed on antigen presenting cells. The expression of MHC class II molecules by mouse T-cells has not been shown unequivocally. In the present work, we demonstrate that activated mouse T-cells synthesize MHC class II molecules de novo and express them on their surface. Further, we have demonstrated that in vitro activated T-cells take up extra-cellular soluble nucleocapsid protein of a morbillivirus. The internalized antigen goes to antigen processing compartment as shown by co-localization of antigen and LAMP-1 using confocal microscopy. We show that activated T-cells express H2M, a chaperone molecule known to have a role in antigen presentation. Further, we demonstrate that activated T-cells process and present internalized extra-cellular antigen to primed T-cells as shown by IL-2 secretion and in vitro proliferation. The presentation of antigen by T-cells may have implications in immuno-regulation, control of infection by lymphotropic viruses and maintenance of immunological memory.
Introduction
The most important steps in the initiation of T-cell immune response is the interaction of T-cells with peptide loaded major histocompatibility complex (MHC) 1 molecules present on the antigen presenting cells. In general, MHC class II molecules bind peptides formed in endocytic organelles. Antigen presenting cells (APCs) synthesize MHC class II molecules which accumulate in late endosomal and lysosomal compartments (collectively termed MIICs) together with other components required for antigen processing [1] . However, an increasing number of diverse cell types besides professional APCs have been documented to express class II molecules and act as accessory cells for T-cell stimulation. These include hepatic KupVer cells [2] , epidermal Langerhans cells [3] , resting and activated B-cells [4] , endothelial cells [5] , astrocytes [6] , eosinophiles [7] , and natural killer cells [8] .
The MHC class II expression characterizes the antigen presenting capacity of a cell. Human, guinea pig, and rat T-cells have been shown to synthesize and express class II molecules on their surface after activation by mitogens or alloantigens [9] [10] [11] [12] . In contrast, the expression of Ia antigens on murine T-cells is still debated. Although expression of Ia antigen by mouse T-cells has been reported [13] [14] [15] [16] , subsequent work has shown that Ia antigens might have been acquired passively from contaminating Ia bearing non-T-cells [17, 18] . These MHC class II expressing T-cells are able to present antigen to other Tcells as reported for human T-cells [19] . In case of mouse T-cells, most of the studies demonstrating MHC class II expression have been carried out using long term cultured T-cells or speciWc T-cell clones. Appearance of MHC class II on naïve mouse T-cells due to de novo synthesis after activation has not been reported.
The expression of MHC class II molecules on activated T-cells can bring about various important immunological functions. Direct MHC class II restricted T-cell-T-cell interactions between TCR peptide speciWc T-cells and MHC class II + T-cells expressing the appropriate TCR have been demonstrated in rat [20] . Similar interactions have been postulated to drive immune responses after T-cell vaccination [21, 22] and to be of importance in T-cell regulation [23] . TCR peptide immunization, which has been used for protection against multiple sclerosis, appears to function through T-T interactions [24] . Idiotypic and anti-idiotypic T-cells interaction had been proposed for maintenance of immunological memory [25] .
In the present work, we report that activated mouse T-cells de novo synthesize and express MHC class II molecules on their surface. Activated T-cells take up extra-cellular soluble antigen (morbillivirus nucleocapsid protein), which is processed in endosome/lysosome for presentation to primed T-cells leading to proliferation and cytokine secretion.
Materials and methods

Animal
Balb/c and C57BL/6 mice were bred and maintained in the Central Animal Facility, Indian Institute of Science, Bangalore, India. Six-to eight-weeks old male mice were used in all experiments.
Reagents
The following antibodies-anti-mouse CD3-PE (clone 145-2C11), puriWed anti-mouse I-A/I-E (clone 2G9), anti-mouse I-A/I-E-PE (M5/114), anti-mouse CD69-biotin (clone H1.2F3), anti-mouse CD11c (clone HL3), anti-mouse-IgM-FITC (clone II/41), puriWed antiinvariant chain (CD74; clone ln-1) and isotype control antibodies as well as recombinant mouse IL-2 were from PharMingen, USA. Polyclonal rabbit anti-mouse Ig and anti-rabbit IgG Cy3 conjugated antibody were purchased from Sigma, USA. Donkey anti-rat IgG-FITC was obtained from Jackson ImmunoResearch Laboratories, USA. Anti-mouse TCR -PE-Cy5 (clone H57-597), puriWed anti-mouse CD28 (clone 37.51), anti-mouse I-A/ I-E-biotin (clone M5/114), Streptavidin-PE, and Streptavidin-FITC were procured from e-Bioscience (USA). Anti-LAMP-1 (1D4B) antibody was from Santa Cruz Biotechnology, USA. Anti-mouse H2M antibody (clone 2C3a) was a generous gift from Dr. L. Karlsson, Johnson & Johnson Pharmaceutical Research and Development, USA. LAMP-1 and H2M antibodies were conjugated with FITC and TRITC, respectively, using standard protocol [26] .
Recombinant Rinderpest virus (RPV) nucleocapsid protein (N) was expressed in Escherichia coli and puriWed as described earlier [27] . RPV nucleocapsid protein has been earlier shown to elicit good CD4 + and CD8 + Tcell responses in vivo and in vitro in the mouse model as well as in cattle [27, 28] .
PuriWcation of T-cells
Mice were sacriWced by cervical dislocation and lymph nodes (inguinal, posterior axillary, internal axillary, and popliteal) were removed. Single cell suspensions were panned for 1 h in FBS coated plate (Falcon). Unbound cells were harvested and complement mediated lysis was performed using anti-mouse Ig, antimouse MHC class II (clone m5/115), anti-mouse CD11c and rabbit complement. Mononuclear cells were puriWed by density gradient centrifugation on Histopaque-1077 (Sigma, USA). Cells were further panned on anti-mouse Ig antibody coated plate for 1 h in complete medium (RPMI-1640 supplemented with 25 mM Hepes, 100 g/ ml penicillin, 100 g/ml streptomycin, 20 g/ml gentamicin, and 10% FBS). Unbound cells were harvested and purity of T-cells was checked by FACS.
In vitro activation of T-cells
PuriWed T-cells (4 £ 10 6 ) were treated with PMA (500 ng/ml) and ionomycin (50 ng/ml) for 6 h in complete medium in a Wnal volume of 1.5 ml in 24-well plates. Cells were harvested and washed with Hank's balanced salt solution. PuriWed T-cells were also activated with IL-2, concanavalin-A, anti-TCR antibody or anti-CD28 and plate bound anti-CD3 antibody. Twenty four well plates were coated with 10 g/ml of either anti-mouse CD3 antibody (145-2C11) or anti-mouse TCR antibody (H57.597) in PBS overnight at 4°C, and then washed with medium. PuriWed T-cells (4 £ 10 6 cells/well) were cultured in anti-CD3 coated plate with soluble anti-CD28 antibody (1 g/ml) or into anti-TCR antibody coated plates in complete medium for 8 h at 37°C in 5% CO 2 incubator. Cells were in vitro activated with concanavalin-A (1 g/ml) or recombinant mouse IL-2 (200 U) in complete medium for 8 h at 37°C in 5% CO 2 incubator. Cells were harvested, washed and stained for MHC class II, and analyzed by FACS.
In vivo activation of T-cells
Balb/c mice were injected with puriWed recombinant nucleocapsid protein of Rinderpest virus (50 g/mouse)
in CFA subcutaneously and sacriWced after 5 days. Single cell suspensions from lymph nodes (inguinal, popliteal, and axillary) and spleen were made. RBCs were removed from spleen using ACK lysis buVer (0.15 mM NH 4 Cl, 1 mM KHCO 3 , and 0.1 mM EDTA). Mononuclear cells were puriWed by density gradient centrifugation using Histopaque-1077. Cells were surface stained for TCR , CD69, I-A/I-E, and isotype control antibodies. Cells were analyzed by FACS.
FACS analysis
PuriWed T-cells were surface stained with puriWed anti-mouse I-A/I-E or anti-mouse CD69-biotin conjugate or isotype control antibodies. BrieXy, cells were incubated in 10% FBS containing PBS for 20 min at 4°C. Cells were washed with PBS containing 0.2% BSA and 0.01% sodium azide, and incubated with antibody conjugates for 30 min on ice. PuriWed antibody or biotin conjugated antibody were used as primary antibodies followed by anti-rat-IgG FITC conjugate or streptavidin-FITC, respectively. Flow cytometric analysis was performed on FACSscan (BD Bioscience, USA) and the data was analyzed using WinMDI 2.8 software.
Confocal microscopy
In vitro activated T-cells (5 £ 10 6 cells/well) were cultured for 3 h in the presence of N protein (100 g/ml) in complete medium. Cells were washed and Wxed with 3% paraformaldehyde for 15 min on ice and permeabilised using permeabilisation solution (e-Bioscience, USA) for 10 min on ice. Cells were incubated with rat anti-LAMP-1-FITC antibody, rat anti-mouse H2M-TRITC antibody, anti-mouse invariant chain antibody, rat anti-I-A/ I-E-biotin antibody or rabbit anti-N antibody for 30 min on ice in the presence of permeabilisation solution. Cells were incubated with secondary antibodies, streptavidin-FITC, streptavidin-TRITC, and anti-rabbit IgG-Cy3 conjugates for 30 min on ice and were washed twice with permeabilising solution and Wnally with PBS. Cells were visualized under confocal microscope using 100£ objective (Leica Microsystems, Germany). In these experiments, isotype control antibody stainings were performed and visualized under microscope. Cells stained with isotype control antibodies have not shown signiWcant Xuorescence (data not shown).
Radiolabelling and immunoprecipitation
Radiolabelling and immunoprecipitations were performed as described earlier [29] . PuriWed T-cells were activated with PMA/ionomycin for 6 h. Before radiolabeling, cells were incubated for 1 h in methionine-deWcient RPMI-1640 (Sigma) supplemented with 5% dialyzed FBS. The cells were then pelleted and re-suspended in the same medium at 4 £ 10 7 cells/ml and metabolically labeled by 20 min pulse incubation with 200 Ci/ ml [ 35 S]methionine protein labeling mix (Perkin-Elmer, USA). After the pulse, the cells were pelleted, unincorporated radiolabel removed by washing, and the cells were resuspended at 2 £ 10 6 cells/ml in ice-cold (0 chase) or prewarmed RPMI medium containing 5% FCS. The cells in the prewarmed media were then incubated for 0.5, 1, 2, or 3 h at 37°C in a 5% CO 2 atmosphere.
After the pulse-chase, the cells were pelleted and lysed in 0.5% Triton X-100, 300 mM NaCl, 50 mM Tris, pH 7.4, and complete protease inhibitor cocktail (PharMingen, USA). Nuclei and debris were removed by centrifugation. The cell lysates were pre-cleared Wrst, by incubation with rabbit anti-mouse IgG (Sigma, USA) and Protein-A-agarose (Bangalore, Genie, India) overnight at 4°C. Lysates were incubated with MHC class II antibody (2G9 clone; PharMingen, USA) for 2 h. Immune complexes were precipitated using Protein-Gagarose (Sigma, USA). Aggregate immune-complexes were washed three times in 0.5% NP40, 30 mM NaCl, 50 mM Tris, pH 7.4. The beads were then resuspended in Laemmli sample buVer containing 3% SDS and either incubated for 1 h at room temperature or boiled for 3 min. The immunoprecipitates were analyzed by electrophoresis using 10% SDS-PAGE. The gels were treated with salicilate and dried. The gel was subjected to Xuorography and exposed to phosphoimager plate for 16 h and scanned.
To detect synthesis of MHC class II molecule by antigen activated T cells, naïve mouse splenocytes (2 £ 10 6 cells/well) were pulsed with N protein (100 g/ml) in 24-well plates in complete medium. Cells were incubated for 12 h and then Wxed with 0.5% paraformaldehyde and used as antigen presenting cells. In vivo antigen primed T-cells were puriWed from lymph node cells of mice 5 days after immunization with N protein (50 g) in Freund's complete adjuvant. These T-cells were cultured in the presence of Wxed antigen presenting cells for 6 h in complete medium and pulse labeled with [
35 S]methionine (200 Ci/ml, speciWc activity 1175 Ci/mmol) for last 2 h of incubation. Cells were lysed and MHC class II was immuno-precipitated and detected by phosphor-imager as described above.
PuriWcation of CD4
+ and CD8 + T-cells CD4 + T-cells were puriWed from T-cell populations by complement mediated lysis of CD8 + T-cells as described earlier [30] . BrieXy, puriWed T-cells were incubated with anti-CD8 antibody (3.155) or anti-CD4 antibody (GK 1.5) on ice for 30 min. Cells were washed and treated with rabbit complement for 20 min on ice, dead cells were removed using Histopaque-1077 density gradient centrifugation. Depletion was checked by FACS using anti-mouse CD4 antibody (clone H129. 19 ) and anti-mouse CD8 antibody (clone 53-6.7) and purity of CD4 + T and CD8 + T cells was >98% (data not shown).
In vitro proliferation assay
PuriWed, in vitro activated T-cells were incubated with puriWed N protein (100 g/ml) in complete medium for 12 h. After incubation, cells were washed with RPMI medium, irradiated (3000 rad) and used as antigen presenting cells (T-APCs) for in vitro proliferation assay. Antigen primed responder T-cells were puriWed from lymph node cells of N immunized mouse 5 days after immunization. PuriWed primed responder cells (4 £ 10 5 cells/well) were incubated with diVerent number of irradiated T-APCs in Xat bottom 96-well plates in a Wnal volume of 200 l and incubated for 72 h in a humidiWed CO 2 incubator. [
3 H]Thymidine (1 Ci/well) (85 Ci/mmol, Perkin-Elmer) was added to cells in the last 16 h of incubation. Cells were harvested on glass Wber Wlters using semi-automated cell harvester (Nunc) and the incorporated radioactivity was measured in a scintillation spectrophotometer.
IL-2 secretion assay
Stimulator cells were generated as described above and Wxed with 0.5% paraformaldehyde for 5 min on ice. Cells were washed and cultured with responder T-cell (5 £ 10 5 cells/well) in a Wnal volume of 200 l in Xat bottomed 96-well plate in complete medium. Culture supernatant was harvested after 36 h of incubation and IL-2 was detected employing IL-2 ELISA kit (e-Bioscience, USA).
RT-PCR analysis
Total RNA was prepared from puriWed PMA/Ionomycin activated T-cells using TRIzol reagent according to manufacturer's instruction (Life Technology, USA). Primer sequences used for ampliWcation of H2M (NM_010386.2), Ii (NM_010545.2), I-A chain (AY452201.1), I-A chain (AY452202.1), I-E chain (X54427.1), and I-E chain (X00958.1) were designed using software from Integrated DNA Technology, USA. The GAPDH, total mCIITA, type I, type III and type IV were as published [31] . The sequence of primers are as follows. GAPDH: sense 5Ј-AACGACCCCTTCATT GAC-3Ј and anti-sense 5Ј-TCCACGACATACTCAG CAC-3Ј (predicted size D 191 bp). H2M : sense 5Ј-ACC CCAGAACGCCCTGCC-3Ј and anti-sense 5Ј-GCTCT TCTGGATGCAAGTCC-3Ј (predicted size D 312 bp). Invariant chain (Ii): sense 5Ј-AGGACACGGCAAAT GAAGTC-3Ј and anti-sense 5Ј-CCATGATCCTAC AGGCTGCT-3Ј (predicted size D 319 bp). I-A chain: sense 5Ј-GGACAACATCTTCCCACCTG-3Ј and antisense 5Ј-GCAGGCCTTGAATGATGAAG-3Ј (predicted sizeD326bp). I-A chain: sense 5Ј-CAACCACCACA ACACTCTGG-3Ј and anti-sense 5Ј-CTGACTCCTGTG ACGGATG-3Ј (predicted size D 346 bp). I-E chain: sense 5Ј-ACACACCATCATCCAGGCAGAGTT-3Ј and anti-sense 5Ј-TCTGGAGTGTTGTTGGAACGC TCT-3Ј (predicted size D 234 bp). I-E chain: sense 5Ј-A AGGACAGTCTGGACTTCAGCCAA-3Ј and antisense 5Ј-AGGGATAAACAGCCATCAGGAGCA-3Ј (predicted size D204bp). Total mCIITA: sense 5Ј-AC GCTTTCTGGCTGGATTAGT-3Ј and anti-sense 5Ј-T CAACGCCAGTCTGACGAAGG-3Ј (predicted sizeD 342 bp). Anti-sense primer for type I, III, and IV mCIITA: 5Ј-GGTCGGCATCACTGTTAAGGA-3Ј. Sense primer type I mCIITA: 5Ј-AAGAGCTGCTCTCACGGGAAT-3Ј (predicted size D 264 bp). Sense primer type III mCI-ITA: 5Ј-TCTTACCTGCCGG AGTT-3Ј (predicted size D 100 bp). Sense primer for type IV mCIITA: 5Ј-GA GACTGCATGCAGGCAGCA-3Ј (predicted size D 129 bp). Reverse transcription of RNA (1 g) into cDNA was performed in the presence of Oligo(dT) 18n primer and RevertAid M-MuLV Reverse Transcriptase (MBI Fermentas) as per manufacturer's instructions. Reverse transcribed cDNA was ampliWed in the presence of speciWc sense and anti-sense primer and DNA Taq polymerase (MBI Fermentas). Thirty cycles of PCR (93°C for 30 s, 57°C for 20 s, 72°C for 20 s) was followed by 5 min extension incubation at 72°C. Negative controls included all reagents and primers without cDNA. GAPDH was ampliWed as positive control. PCR products were resolved on 2.0% agarose gels and were conWrmed by size comparison with 100 bp ladder.
Results
Expression of MHC class II by activated T-cells
To test for cell surface expression of MHC class II molecules by activated mouse T-cells, puriWed T-cells from naïve mice were stimulated in vitro with phorbol 12-myristate 13-acetate (PMA) and ionomycin. The purity of T-cells was detected by FACS after staining with anti-CD3, anti-CD11c and anti-IgM antibody and they are 99% pure (Fig. 1) . The combination of PMA/ ionomycin is routinely used as a TCR-independent model to study T-cell activation and proliferation [32, 33] . PMA/ ionomycin treatment has been shown to positively select CD4 + T-cells in thymocyte cultures [34] and modulate T helper and T cytotoxic subsets [35] . Activation of T-cells after treatment with PMA/ionomycin was monitored by FACS after staining with CD69, a very early activation marker. Our result shows that all cells are activated after PMA/ionomycin treatment ( Fig. 2A) . We have monitored the expression of MHC class II molecules on naïve mouse T-cells after in vitro activation with PMA/ionomycin and the results are shown in Fig. 2B , which demonstrates the expression of MHC class II molecules. To detect the expression of MHC class II on CD4 + and CD8 + T-cells, puriWed CD4 + or CD8 + T-cells were activated in vitro with PMA/ionomycin and stained for MHC class II molecule. The results (Fig. 2C) show that CD4 + T-cells express MHC class II molecules but not CD8 + T-cells. We observed that surface expression of MHC class II on puriWed CD4 + CD8 + mixed T-cells (Fig. 2B, iii) is almost similar to that expressed on puriWed CD4 + T cell (Fig. 2C ). This MHC class II staining in the mixed population is probably due to acquisition of MHC class II by CD8 + T cells from CD4 + T-cells as it has been reported earlier that activated CD8 + T-cells acquire surface molecules from other cells [36] [37] [38] . When we analyzed the expression of MHC class II on mixed population of puriWed T-cells, we see the presence of MHC class II on both CD4 + and CD8 + T-cells which could be due to acquisition of MHC class II from CD4 + T-cells by CD8 + T cells (Fig. 2B, v and vi) . Further, expression of MHC class II in cells activated by concanavalin-A, plate bound anti-CD3 and soluble anti-CD28, plate bound anti-TCR antibody or puriWed recombinant IL-2 was tested. The results (Fig. 2D) show that Tcells after activation by the above-mentioned reagents also express MHC class II molecules.
To obtain evidence for the expression of MHC class II by T-cells activated in vivo, mice were immunized with N protein and after 5 days, the expression of MHC class II was tested. The results given in Fig. 3 show that in vivo activated T-cells express MHC class II molecules on their surface. However, this experiment cannot completely rule out the possibility of passive acquisition of MHC class II molecules from other APCs as reported earlier [17, 18] .
De novo synthesis of MHC class II molecules by activated T-cells
Mouse T-cells have been shown to acquire MHC II from professional antigen presenting cells [18, 39] . To test for de novo synthesis of MHC class II, puriWed T-cells from naïve mouse were activated in vitro and metabolically labeled with [ (Fig. 4A) . Two protein bands (»33 kDa and »28 kDa) seen in Fig. 4A and B correspond to the MHC class II and chain, respectively. MHC class II expression was further conWrmed in antigen driven activated T-cells. The results shown in Fig. 4B demonstrate that antigen driven (N protein) activation also leads to expression of MHC class II molecules.
SDS-stable complex formation was monitored by SDS-PAGE under non-reducing condition. MHC class II antibody speciWc for chain was used, which immunoprecipitates both and chain along with Ii molecules [29] . Co-immunoprecipitation of chain by MHC class II antibody indicates that a signiWcant fraction of the newly synthesized class II molecules formed dimers shortly after synthesis. The band for chain appears denser than the chain band in the immunoprecipitate because newly synthesized Ii chain co-migrates with chain under the condition used for these experiments (Fig. 4A) . After 1-2 h, however, an increasing fraction of and chain migrated as a band of 52-55 kDa, (C[ / ], Fig. 4A ). Since these proteins are sensitive to boiling in SDS (Figs. 4A and B) , it is indicative of "compact" peptide loaded / dimers [29, [40] [41] [42] . Apart from the C[ / ], we also see another band F[ / ] appearing as early as 0.5 h which represents the dimers formed by immature and chain of MHC class II as reported earlier [29, 43] . Aggregates present in the not-boiled samples dissociated and migrated at »47 kDa and above. This is probably due to immature stable dimers of chains or disulphide bonded chain with other ER proteins as reported earlier [29, 43] . We also see the presence of Ii polypeptide by Fig. 1 . Purity of T-cells. T-cells were puriWed from naïve mouse as described in Section 2. Cells were stained with Xuorochrome-conjugated antibodies and isotype control antibodies. The purity was detected by FACS. Marker (M1) were set according to isotype control antibody staining.
Western blot in the boiled sample using anti-mouse Ii antibody which conWrmed the co-migration of Ii with chain (data not shown).
To further conWrm the Wnding that MHC class II is endogenously synthesized and transported to the surface of activated mouse T-cells, the cells were treated with brefeldin-A during activation and stained for surface MHC class II. Brefeldin-A is known to block the transport of protein from endoplasmic reticulum to Golgicomplex thereby inhibiting the transport of molecules to the surface of cells [44, 45] . The data given in Fig. 4C show that MHC class II expression on the surface of activated T-cells is blocked by brefeldin-A treatment.
Co-localization of LAMP-1, H2M, MHC class II, and antigen
In order to investigate whether external antigens taken up by activated T-cells undergo processing through the standard pathway for class II presentation, the expression of LAMP-1, a late endosome-lysosome marker was tested in the activated T-cells. To demonstrate that internalized antigen goes through MHC class II processing pathway, cells were pulsed with N antigen and co-localization of LAMP-1 and antigen was visualized by confocal microscopy. The results shown in Fig. 5A demonstrate that LAMP-1 is co-localized with N protein indicating that N protein has gone into the antigen-processing compartment. To detect the number of T-cells which have taken N protein, we have performed FACS analysis and results show that 80% activated T-cells were N positive (data not shown). To provide further support for the MHC class II processing pathway in activated Tcells, the expression of H2M and MHC class II molecules together (Fig. 5B) or individually with Lamp-1 ( Fig. 5C and D) in T cells were monitored by confocal microscopy. H2M is a chaperone molecule, which plays a crucial role in loading of peptide on major histocompatibility class II molecules in lysosomal compartments [46] . It is interesting to note that the expression of H2M and MHC class II are co-localized in the late endosome/lysosome in activated T-cells. Results given in Figs. 5C and D show that H2M and MHC class II molecules are present in this compartment where antigen processing takes place. In all the staining, cells were stained with isotype control antibody, which does not give any signiWcant Xuorescence (data not shown).
Expression of mRNA for Ii, H2M chain, I-A chain, I-A chain, I-E chain, I-E chain and CIITA by activated T-cells
To detect the generation of mRNA for Ii, H2M , I-A chain, I-A chain, I-E chain, I-E chain and CIITA in activated T-cells, RT-PCR of RNA from activated Tcells was carried out. As shown in Fig. 6A , mRNA for these molecules are present in activated T-cells but not in naïve T-cells of Balb/c mice. Since C57Bl/6 inherently lack MHC class II IE because of a naturally occurring defect in the Ea, gene making them class II IA + IE ¡ [47] . We have used T-cells from C57BL/6 strain of mice as genetic control for the RT-PCR analysis and shown that activated C57BL/6 T-cells express I-A molecules but not the I-E molecules (Fig. 6B) .
The expression of Ii, H2M , and MHC class II molecules is controlled by class II transactivator protein (CIITA). The CIITA has been referred to as the "master control factor" for these molecules [31, 48, 49] . Therefore, we have examined the expression of CIITA in activated mouse T cells. CIITA expression is regulated by three promoters (pI, pIII, and pIV), producing type I, type III and type IV CIITA [31] . Recently it has become clear that the restriction of these promoters to diVerent cell types or with various stimuli is not so simple [31, 48] . We observed that activation dependent expression of CIITA in mouse Tcells involves promoter I and IV but to lesser extent promoter III in PMA/ionomycin activated T-cells (Fig. 6C) . It is interesting to note that we also observed a very faint band in un-activated T-cells (total CIITA and type IV CIITA). This low level expression of CIITA is probably not suYcient to drive the expression of MHC class II and other molecules as reported earlier [50, 51] . In normal activated splenocytes (un-fractionated T cells) the expression of all three type CIITA is seen (data not shown).
Activated T-cells process and present extra-cellular antigen to other T-cells
To examine whether mouse T-cells can also present external antigen to other T-cells, puriWed activated Tcells, were pulsed with Rinderpest virus nucleocapsid protein, and irradiated after 12 h of culture. These cells were used as antigen presenting cells (T-APCs) in an in vitro proliferation assay. The results shown in Fig. 7A demonstrate that T-APC is able to present antigen to primed, speciWc T-cells. When activated T-APCs were pulsed with antigen in the presence of chloroquine, they do not stimulate primed T-cells showing that antigen processing has been inhibited in these cells. To test if proliferation signal is coming through MHC class II, Immune-complexed bead were divided into two fractions. One fraction was incubated for 1 h at room temperature in Laemli sample buVer (I) and other fraction was boiled for 3 min (II). Samples were analyzed by 10% SDS-PAGE followed by phosphor-image analysis. Splenocytes were activated with PMA/ionomycin for 1 h and pulsed with 
Discussion
In the present work, we have examined the expression of MHC class II molecules and explored the antigen presenting capacity of activated mouse T-cells. The expression of MHC class II molecules in mouse T-cells has been reported using T-cell clones or T-cell lymphoma but not in naïve T-cells [13] [14] [15] [16] 52, 53] . In most of these studies, T-cells were cultured in the presence of mitogens or IL-2. In the present work, we show that culturing of T-cells in the presence of various mitogens leads to expression of MHC class II molecules. Earlier reports on absence of MHC class II expression in long-term cultured speciWc T-cell clone or -cell lines, needs to be reexamined in the context of expression or defect in the expression of CIITA, which is a master controlling factor. There are reports that activated T-cell acquires MHC class II molecules from other antigen presenting cells [17, 18, 39] . We also observe the presence of MHC class II molecules on ex vivo activated T-cells by FACS. However, FACS analysis does not diVerentiate between de novo synthesized and passively acquired MHC class II molecules.
In our experimental system, since the cells were activated in vitro in the absence of professional antigen presenting cells, increased expression of MHC class II on the surface is possible via intracellular synthesis, and not by acquisition of MHC class II molecules from other APCs as has been reported earlier [17, 18] . Metabolic labeling of newly synthesized MHC class II with [ 35 S]methionine followed by immunoprecipitation conWrms de novo synthesis. The results demonstrate that class II molecules are synthesized endogenously after activation with either PMA/ionomycin or with antigen pulsed APCs. Our result also correlates with earlier published report for other species [11, 12, 19] . This is further Fig. 6 . Activated T-cells synthesize mRNA encoding Ii, I-Ad chain, I-Ad chain, H2M , and CIITA. PuriWed T-cells were activated with PMA/ionomycin for 3 h. cDNA were synthesized using oligo(dT) 18n primer and expression of transcripts were detected by RT-PCR using gene speciWc sense and anti-sense primers. GAPDH was used as an internal control. Products were electrophoresed through 2% agarose gel. (A) Lanes 1, 3, 5, 7, 9, 11, and 13 represent the proWle of transcript from the naïve T-cells. Lanes 2, 4, 6, 8, 10, 12 , and 14 represent proWle of activated T-cells. (B) T-cells from C57BL/6 mice were puriWed and activated in vitro. Expression of gene was detected by RT-PCR as described above. (C) Expression of CIITA was tested as described earlier [31] . conWrmed by inhibition of surface expression of MHC class II by brefeldin-A. Thus, naïve mouse T-cells are capable of synthesizing MHC class II de novo after activation with mitogens or even by antigen driven activation. Although, MHC class II expression in long term cultured cloned T-cells or T-cell lymphoma or thymus derived cells has been shown [13, 14, 16] , the present work demonstrates that activated mouse T-cells can synthesize MHC class II molecules de novo. Using pulse labeling, immunoprecipitation and analysis of immune complexes under denaturing and non-denaturing condition, we show that newly synthesized MHC class II molecules form SDS-stable complexes similar to that reported for other antigen presenting cells [29] . In addition, the synthesis of transcripts for I-A chain, I-A chain, I-E chain, I-E chain, Invariant chain, H2M in activated mouse T-cells was conWrmed by RT-PCR analysis. The expressions of these molecules are controlled by class II transactivator protein (CIITA) [48, 54] . It has also been reported that CIITA knockout mice express MHC class II albeit at a Wve-fold reduced level [55] . We have examined the expression of CIITA by RT-PCR and interestingly, we Wnd that mouse T-cells use predominantly type I and type IV exon of CIITA but very little of type III exon in comparison to rat T-cells where the usage of type III and type IV exon of CIITA has been reported [12] . Though mouse T-cells express class II transactivator (CIITA), a 'master regulator factor', yet it is not suYcient to drive the expression of MHC class II molecules in naïve cells [48] . The functional activation of CIITA involves phosphorylation of CIITA which can be achieved from signaling through mitogenic triggering [56] [57] [58] . Recently, it has been shown that over-expression of CIITA in mouse T-cells leads to induction of tolerance and altered Th1/Th2 balance [59] .
Professional antigen presenting cells are known to take up, process and present extra-cellular soluble antigens to T-cells. T-cells are known to express CD40, CD40L and B7 co-stimulatory molecules in activated state, which are needed for activation of responder Tcells, enhanced cell cycle progression and survival [19, 33, 60] . Antigen presentation by resting or naïve Tcells is known to induce anergy to responder T cells [61] and apoptosis in other T-cells [62] perhaps because of lack of co-stimulatory molecules on T-APCs. We explored the possibility of intake of soluble antigen by activated mouse T-cells by pulsing with Rinderpest virus nucleocapsid protein in complete medium for 3 h. The results show that activated T-cells take up antigen. Subsequently by confocal microscopy, we have shown that LAMP-1, a late endosomal and lysosomal marker [63] , is seen as part of a cluster in vesicles, indicating that vesicles have been formed during the antigen processing pathway. Co-localization of LAMP-1 with antigen in activated T-cells demonstrates that antigen has entered into the endosomal compartment for processing. We show that H2M is also expressed in activated T-cells, which is an essential molecule for presentation of peptide on MHC class II. These results show that activated mouse T-cells express H2M molecules required for antigen presentation. We have also examined the expression of Invariant chain (Ii) in activated mouse T-cells by confocal microscopy. The results demonstrate that Ii molecules are present in activated T-cells (data not shown). The invariant chain functions as a chaperone protein for MHC class II molecules during folding, assembly and transport from endoplasmic reticulum to Golgi complex [29, 43] . It has been reported earlier that Ii chain is not only required for dimerization or at least partial folding of and chains but also required to allow newly synthesized class II molecules to escape the quality control mechanism in the ER that prevents the transport of misfolded proteins [29] . The presence of lysosomal enzymes associated with antigen processing remains to be demonstrated.
The functional importance of processing and presentation was examined by in vitro proliferation of primed T-cells and IL-2 secretion. The results show that activated T-cells are capable of presenting antigen to primed T-cells as has been reported in case of human and rat [11, 19, 64] . Further inhibition of processing of extracellular antigen was demonstrated using chloroquine, a known inhibitor of lysosomal enzymes by increasing the pH [65] . Proliferation and IL-2 secretion are shown to be MHC class II dependent since anti-MHC class II antibody inhibits this function. This shows that the antigen was processed by lysosomal proteolytic enzymes and presented on surface, which is able to functionally trigger the antigen speciWc T-cells.
We have demonstrated that activated murine CD4 + T cells can process and present antigen through MHC class II molecules. Antigen presentations by T-cells have far-reaching biological consequences. Antigen presentation by T-cells may play a key role in controlling infection by lymphotropic viruses [66, 67] . Perhaps, lymphotropic viruses on infecting T-cells regenerate a quick response bringing in both CD4 + help and CTL attack on infected T-cells. Therefore, antigen presentation by T-cells provides an ideal mechanism to protect immune machinery involving T-cells, which needs experimental veriWcations. The presentation of antigen by Tcells leads to T-cell-T-cell interactions which may lead to proliferation and/or regulation of cognate T-cells as found in auto-immune diseases [20] . T-cell-T-cell interaction has also been proposed to be the basis of T cell vaccination [21] .
